Specialist Registrar in Gynaecology with broad experience in academic translational research. Focus on the role of hormones across lifespan, systems medicine approach and adaptive and maladaptive epigenetic changes. Multidisciplinary approach to develop digital clinical tools for personalised risk prediction, especially when and how to use 'omics' (genomic, epigenomic, metabonomic approaches) in diagnosis, management and ultimately in the prevention of disease. Other areas of interest include teaching, mentoring, patient-driven digital health, and reproductive ethics. I believe being a doctor is first and foremost about being an attentive listener, understanding what matters for each individual patient at a given moment, and then to enter into dialogue to empower them to make evidence-based choices about their health.

I serve as the Assistant PI and Study Coordinator of the FORECEE (4C) Study, whose purpose is to identify novel ways of predicting and ultimately preventing women's cancer. I contribute to research into the how to best optimise pan-omic testing (genetic, epigenetic, metabonomic etc.) for cancer risk prediction in healthy women and for women with a BRCA alteration. I am also interested in implementation-related themes such as barriers to testing, risk communication and decision-making support, ethical implications, and health behaviour in response to testing. 

Supported by a £20k development grant from UCL, I created a free six-week course called Making Babies in the 21st Century (www.makingbabies.info), which so far has had over 19,000 learners enrolled from over 80 countries. 

In 2016, I set up the Antony Silverstone Fellowship (www.silverstonefellowship.org), to support clinical service improvements at the UCLH Maternity Service that focus on enhancing the patient-provider relationship.